resources

Case Studies

MaxQ AI is a healthcare-technology company developing innovative medical-diagnostic artificial- intelligence (AI) software to augment physicians’ care-path decisions in their daily practices.

We make a meaningful impact in the acute-care space with a focus on a broad range of deep and proven clinical and technology suite of applications. Our initial applications aspire to change the diagnostic paradigm by partnering with physicians to comprehensively, seamlessly, and securely tackle common and costly diseases.

Accipio Ix: Identifies Missed ICH in Head Trauma Patient. Capital Health. A Case Study.
As the magnitude of the patient-care load increased at Capital Health hospital in New Jersey, MaxQ AI’s Accipio Ix has proven to be a seamless, powerful, and simple solution assisting the skilled physician team. For one patient, this trusted solution could have made a major difference.

The Use Of Accipio Ax Could Have Helped Avoid the Errant administration of tPA. A Case Study.
Correctly identifying suspected intracranial hemorrhage (ICH) could help prevent the in-error administration of tPA to a stroke patient. Assistance in ICH identification for stroke-treatment care can make a difference. This case study outlines the impact of utilizing AI solutions to empower the physician’s treatment decision.

The Use Of Accipio Ax Could Have Led to Faster ICH Identification. A Case Study.
Previously missed ICH, could become a possible “never event.” During the evaluation of MaxQ AI’s ACCIPIO ICH and Stroke Suite at an acute hospital facility, this was the goal. For stroke patients, early adoption of this AI solution could have an impact on critical decisions in the treatment path and save precious time. This case study outlines the impact of utilizing AI solutions to empower the physician treatment decision.

Accipio Ix: How AI Can Help Identify ICH in Head Trauma Patients. A MaxQ Employee’s Personal Case Study.
As the magnitude of the patient care load increases and the cost of preventable errors grows, MaxQ AI’s Accipio Ix has proven to be a seamless, powerful, and simple solution assisting the skilled physician team in identifying and prioritizing patients with suspected intracranial hemorrhage (ICH). For one patient, the grandmother of a MaxQ AI employee, this trusted solution could have made a difference in avoiding a preventable error and reducing care delays.

White papers

MaxQ AI is at the forefront of transforming healthcare by empowering physicians to provide “smarter care” through intelligent imaging with actionable insights.

We are committed to harnessing the power of artificial intelligence (AI) to raise the level of acute care in hospitals all around the world. We strive to deliver expert results to the physicians that save lives, improve care quality, and lower healthcare costs.

Data Industrialization Security. A White Paper
MaxQ AI is a leading healthcare AI company innovating diagnostic solutions where patient assessment, speed to diagnosis, and healthcare economics converge. We leverage medical-imaging data to develop software-based medical devices for prioritization through identification, annotation, and negative triage. This effort requires a heightened sense of information-security standards, granular data privacy, and integrity measures. In 2017, MaxQ AI began using the phrase ‘Data Industrialization’ to represent the end-to-end life cycle for data mining and treatment in support of software-based medical devices. This white paper explores the methods we use to help ensure the utmost security during Data Industrialization within the use of our products.

ACCIPIO — Solution Architecture and Design. A White Paper
MaxQ AI is ushering in a new era of AI-augmented healthcare through a comprehensive, seamless, and secure suite of patient-level medical diagnostic solutions. We aim to empower care providers around the world to better prioritize life-threatening conditions, such as stroke and head trauma in acute-care settings. These solutions will help across the diagnosis, prognosis, and therapeutic pathways; potentially saving lives, improving the quality of care, and lowering healthcare costs.

RECORDINGS

The MaxQ AI software suite is being designed to comprise several AI applications branded under the name ACCIPIO (meaning “to learn” in Latin).

ACCIPIO uses artificial intelligence for the comprehensive, seamless, and secure assessment of non-contrast head CT for intracranial-hemorrhage (ICH) prioritization, triage, annotation, quantification, and rule-out.

Videos

At MaxQ AI, we are revolutionizing acute care and treatment with the help of world-class clinical partners and state-of-the-art technology.

Our global influence in the new era of AI-empowered care will make it possible for all physicians to access expert-level insights across the diagnosis, prognosis, and therapeutic pathways, making an important difference in the lives of patients and physicians alike.